RMD Open (Mar 2022)

Sustained and improved guselkumab response in patients with active psoriatic arthritis regardless of baseline demographic and disease characteristics: pooled results through week 52 of two phase III, randomised, placebo-controlled studies

  • Joseph F Merola,
  • Atul Deodhar,
  • Philip J Mease,
  • Shihong Sheng,
  • Iain B McInnes,
  • Soumya D Chakravarty,
  • Elena Schiopu,
  • Yanli Wang,
  • Wolf-Henning Boehncke,
  • Christopher T Ritchlin,
  • Alexa P Kollmeier,
  • Xie L Xu,
  • Yusang Jiang,
  • May Shawi,
  • Stephen Xu,
  • John Tesser

DOI
https://doi.org/10.1136/rmdopen-2022-002195
Journal volume & issue
Vol. 8, no. 1

Abstract

Read online

No abstracts available.